Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing caproate

Short- and medium chain carboxylic acids (SCCA/MCCA) are natural antimicrobials produced by fermentation and chain elongation, but currently only a few SCCA/MCCA are used in food-related applications. With the aim to diversify the SCCA/MCCA profile of fermentates for biopreservation, we designed bioprocesses employing bacterial or multi-kingdom consortia to produce caproate-containing fermentates using a targeted cross-feeding strategy. We combined Limosilactobacillus reuteri, Clostridium kluyveri, and Saccharomyces cerevisiae, and quantified substrates utilization and metabolites. The antimicrobial activity of SCCA/MCCA and fermentates was analysed in vitro and in a meat model system. In a first bioprocess, the addition of ethanol (EtOH) initiated caproate formation by the bacterial consortium with levels of 63.9 mM (7.4 g L<sup>-1</sup>) after 22 days. Next, we run two shorter bioprocesses (12 days) and more caproate (28.9 mM, 3.4 g L<sup>-1</sup>) was produced if EtOH was regularly added than without EtOH supplementation (21.7 mM, 2.5 g L<sup>-1</sup>). When S. cerevisiae was included, 37.9 ± 11.4 mM (4.4 g L<sup>-1</sup>) caproate was formed without EtOH addition. Beyond the intended cross-feeding activity, consortia produced and re-metabolised mannitol and glycerol. Lactate and caproate were the major carboxylic acids in fermentates. Caproate inhibited bacteria, yeast and molds at pH 4.5 and 6.5 in vitro, while lactate and caproate acted synergistically in minced meat. Fermentates conferred antimicrobial activity against indicator microbes mostly at pH 4.5 and to a lesser extent at pH 6.5. In this study we successfully designed a consortium to produce caproate. We provide evidence that caproate-containing fermentates had strong antimicrobial activity, and our results indicate the complexity of metabolic interactions that occurred within consortium members. KEY POINTS: • Design of a self-contained bioprocess with multi-kingdom consortium. • Cross-feeding of bacteria and yeast to produce caproate fermentates. • Fermentates containing caproate inhibited bacteria, yeast and mold growth.

Authors

Institutions

Publication Details

Journal
Applied Microbiology and Biotechnology
Published
2026-02-27
DOI
https://doi.org/10.1007/s00253-026-13718-z
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing caproate

Clarissa Schwab, Menşure Elvan, María Florencia Bambace, Angeliki Marietou et al.
Applied Microbiology and Biotechnology
Probiotics and Fermented Foods
article

Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing caproate

Clarissa Schwab, Menşure Elvan, María Florencia Bambace, Angeliki Marietou, Ker Sin Ng, Kirsten Wiborg Jensen, Kathrine Gravlund Fønss, Ulrik Kræmer Sundekilde, Adrien Schneider, Aviaja Kristiansen Aarseth, Annika Regnet
article en

Abstract

Short- and medium chain carboxylic acids (SCCA/MCCA) are natural antimicrobials produced by fermentation and chain elongation, but currently only a few SCCA/MCCA are used in food-related applications. With the aim to diversify the SCCA/MCCA profile of fermentates for biopreservation, we designed bioprocesses employing bacterial or multi-kingdom consortia to produce caproate-containing fermentates using a targeted cross-feeding strategy. We combined Limosilactobacillus reuteri, Clostridium kluyveri, and Saccharomyces cerevisiae, and quantified substrates utilization and metabolites. The antimicrobial activity of SCCA/MCCA and fermentates was analysed in vitro and in a meat model system. In a first bioprocess, the addition of ethanol (EtOH) initiated caproate formation by the bacterial consortium with levels of 63.9 mM (7.4 g L<sup>-1</sup>) after 22 days. Next, we run two shorter bioprocesses (12 days) and more caproate (28.9 mM, 3.4 g L<sup>-1</sup>) was produced if EtOH was regularly added than without EtOH supplementation (21.7 mM, 2.5 g L<sup>-1</sup>). When S. cerevisiae was included, 37.9 ± 11.4 mM (4.4 g L<sup>-1</sup>) caproate was formed without EtOH addition. Beyond the intended cross-feeding activity, consortia produced and re-metabolised mannitol and glycerol. Lactate and caproate were the major carboxylic acids in fermentates. Caproate inhibited bacteria, yeast and molds at pH 4.5 and 6.5 in vitro, while lactate and caproate acted synergistically in minced meat. Fermentates conferred antimicrobial activity against indicator microbes mostly at pH 4.5 and to a lesser extent at pH 6.5. In this study we successfully designed a consortium to produce caproate. We provide evidence that caproate-containing fermentates had strong antimicrobial activity, and our results indicate the complexity of metabolic interactions that occurred within consortium members. KEY POINTS: • Design of a self-contained bioprocess with multi-kingdom consortium. • Cross-feeding of bacteria and yeast to produce caproate fermentates. • Fermentates containing caproate inhibited bacteria, yeast and mold growth.

Applied Microbiology and BiotechnologyVol. 110(1)
Aarhus University (DK)
Openalex Percentile: Top 41%
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.